Table 1 Selected clinical practice guidelines on the pharmacological treatment of unipolar MDD
Guideline | Country |
|---|---|
Depression in Adults: Recognition and Management, by the National Institute for Health and Care Excellence (NICE), 2020 [12] | England |
Unipolare Depression, by the Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN), 2015 [13] | Germany |
Practice Guideline for the Treatment of Patients with Major Depressive Disorder, by the American Psychiatric Association (APA), 2010 [14] | United States |
Clinical Guidelines for the Treatment of Major Depressive Disorder, by the Canadian Network for Mood and Anxiety Treatments (CANMAT), 2016 [15] | Canada |
Antidepressants in Treatment of Adults with Depression, by the World Health Organization (WHO), 2012 [16] | Global |
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorder, 2013 [17] | Global |
Multidisciplinary Guideline for Treatment of Depressive Disorders, by the Trimbos Institute, 2013 [10]; including the Addendum for Treatment of Elderly Patients, Trimbos Institute, 2008 [18] | The Netherlands |